Scarica l'app Stockscreener
3.09
1.34%
0.11
Precedente Chiudi:
$2.98
Aprire:
$3
Volume 24 ore:
27,315
Relative Volume:
0.16
Capitalizzazione di mercato:
$25.19M
Reddito:
$7.50M
Utile/perdita netta:
$-9.85M
Rapporto P/E:
-2.2351
EPS:
-1.3825
Flusso di cassa netto:
$-24.56M
1 W Prestazione:
-6.79%
1M Prestazione:
+7.09%
6M Prestazione:
-4.73%
1 anno Prestazione:
+8.83%
Intervallo 1D:
$2.99
$3.1905
Intervallo di 1 settimana:
$2.90
$3.30
Portata 52W:
$2.52
$12.15
Evaxion A S Adr Stock (EVAX) Company Profile
Compare EVAX vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVAX
Evaxion A S Adr
|
3.02 | 27.36M | 7.50M | -9.85M | -24.56M | -1.3825 |
VRTX
Vertex Pharmaceuticals Inc
|
552.88 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
846.96 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,044.42 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
148.74 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
207.48 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Evaxion A S Adr Stock (EVAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-19 | Iniziato | Maxim Group | Buy |
| 2024-04-02 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2024-02-12 | Iniziato | H.C. Wainwright | Buy |
Evaxion A S Adr Borsa (EVAX) Ultime notizie
Evaxion Biotech Earnings Call: Data Strength, Cash Strain - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
Evaxion Biotech A/S Adr (EVAX) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1 - GlobeNewswire Inc.
European ADRs Rose As Biopharma Names Led The Pack - Finimize
US-Traded European Stocks Slipped As Arm And ArcelorMittal Fell - Finimize
Evaxion A/S Sponsored ADR Actuals & Estimates (NASDAQ:EVAX) - TradingView
European ADRs Edged Higher As Biotech Led Friday’s Moves - Finimize
Evaxion receives Prix Galien UK Award for Best digital health solution - Finansavisen
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia - Finansavisen
European ADRs Started The Week In The Green - Finimize
European ADRs Edged Higher In US Trading - Finimize
EVAXEvaxion A/S ADR Options - Finviz
Evaxion Biotech Signals Strong R&D Momentum Amid Cash Constraints - TipRanks
Most VolatileStock ScreenerNews - Finviz
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer - Finansavisen
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial - Finansavisen
Evaxion concludes Annual General Meeting - Finansavisen
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01 - Finansavisen
Endesa S.A. – Unsponsored ADR (OTCMKTS:ELEZY) Given Average Rating of “Strong Sell” by Brokerages - Defense World
Top GainersStock ScreenerSnapshot - Finviz
Experience real-time quotes, in-depth charts, and analyst ratings - webull.com
Notice to convene Evaxion’s Annual General Meeting - Finansavisen
Europe’s US-Listed ADRs Rose, Led By Solar And Biotech - Finimize
European ADRs Rose, While Biotech Names Did The Heavy Lifting - Finimize
Evaxion Biotech Earnings Call Highlights AI and Runway - TipRanks
Evaxion A/S (NASDAQ:EVAX) Receives Buy Rating from HC Wainwright - Defense World
Evaxion A/S (NASDAQ:EVAX) Price Target Cut to $9.00 by Analysts at Lake Street Capital - Defense World
Evaxion Earnings Report: Q4 Overview - Sahm
Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Short Interest Up 20.9% in February - Defense World
Evaxion Biotech's Earnings: A Preview - Sahm
European ADRs Slip Slightly As Winners And Losers Split - Finimize
European Biotech Stocks Outperformed As Broader Market Dipped - Finimize
European Pharma And Biotech Companies Led ADR Gains In The US - Finimize
Evaxion Stock Climbs Amid Biotech Surge - StocksToTrade
Evaxion Biotech A/S Announces Change in American Depositary Shares Ratio to Enhance Liquidity - nasdaq.com
Evaxion A/S (EVAX) Stock Forecast and Price Target 2026 - MarketBeat
Why Is Cancer Therapy Focused Evaxion Biotech Stock Trading Higher Today? - Sahm
Evaxion Biotech (EVAX) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength - Stocktwits
What is the current Price Target and Forecast for Evaxion A/SSponsored ADR (EVAX) - Zacks Investment Research
Top movers in Friday's pre-market session - ChartMill
Evaxion Biotech (EVAX) Stock Price Soared 236.9% Premarket Amid Buying Pressure - AskTraders
Top movers in Wednesday's after hours session - ChartMill
Evaxion A S Adr Azioni (EVAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.18%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):